Article
Thomas Stinchcombe, MD, assistant professor of clinical research, UNC Lineberg Comprehensive Cancer Center, discusses the treatment of patients with non-small cell lung cancer (NSCLC).
Thomas Stinchcombe, MD, assistant professor of clinical research, UNC Lineberg Comprehensive Cancer Center, discusses the treatment of patients with non-small cell lung cancer (NSCLC). In order to manage cost, Dr Stinchcombe says that molecular testing allows clinicians to pick the correct treatment for the patient.
This video was taken on November 8 at the NAMCP Fall Managed Care Forum in Las Vegas, NV.
The Importance of Examining and Preventing Atrial Fibrillation
Studies Highlight Heavy Burden on Caregivers of Patients With DMD
Tuberculosis Through Time: Historic Burden, Modern Challenges